HIGHLIGHTS
- who: Genomic Alterations and collaborators from the Levine Cancer Institute, Atrium Health, Charlotte, NC , Tempus Labs Inc, Chicago, IL , University of Genoa, Ospedale Policlinico San Martino IRCCS, Genoa, Italy , West Cancer Center, Germantown, TN , University of Florida, Gainesville, FL , University Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, Belgium have published the Article: Landscape of KRAS , Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS -Mutated Cancers, in the Journal: (JOURNAL) of February/15,/2022
SUMMARY
The recent development of KRAS G12C-selective inhibitors of GTP binding-locking KRAS in an inactive state5 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.